Economic Evaluation of a Novel MicroRNA-Based Assay to Determine Risk of Late Genitourinary Radiation Toxicity in Patients With Prostate Cancer

Jacie T. Cooper, John E. Schneider · 2025

Read Economic Evaluation of a Novel MicroRNA-Based Assay to Determine Risk of Late Genitourinary Radiation Toxicity in Patients With Prostate Cancer by Jacie T. Cooper, John E. Schneider (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12714312.txt.

Description

Jacie Cooper and John Schneider weigh, in a 2025 study, the cash case for a gene test that calls late ray harm in prostate cancer care. Rays cure, yet late water-way harm can last for life, and risk swings by man. No proved tool calls that risk for a man by his own traits. The test, PROSTOX ultra, reads small RNAs to grade risk for a set ray form. With it, plans can steer a man to the ray kind his body bears best. A split tree plus state model frames the sums, for five-year cost and life-long worth.

Cost shifts and life-grade gains from less late harm are the outs. The frame sets what the test must earn to pay its way.

Catalog record

CREATORJacie T. Cooper, John E. Schneider
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12714312

Browse the full library · About the Tower of Babel